NASDAQ (usa) arrow 6715.56 -12.11 -0.18%
FTSE 100 (london) arrow 7487.96 -5.12 -0.07%
DAX (german) arrow 13465.51 235.94 1.78%
NIKKEI 225 (japan) arrow 22420.08 408.47 1.86%
Hang - Seng (hong kong) arrow 28594.06 348.52 1.23%
NIFTY - 50 (india)
Straits Times (singapore) arrow 3391.61 17.53 0.52%
KOSPI (korea) arrow 2556.47 33.04 1.31%
All Ordinaries (australia) arrow 6005.30 28.90 0.48%
BOVESPA (brazil) arrow 74092.76 -215.73 -0.29%

Novo Nordisk A/S (CO: NOVO-B)

 
NOVO-B Technical Analysis
5
As on 30th Jan 2026 NOVO-B STOCK Price closed @ 369.55 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 479.44 & Strong Sell for SHORT-TERM with Stoploss of 652.91 we also expect STOCK to react on Following IMPORTANT LEVELS.
 
 

NOVO-BSTOCK Price

Open 366.55 Change Price %
High 377.65 1 Day -0.85 -0.23
Low 366.45 1 Week -4.30 -1.15
Close 369.55 1 Month 48.40 15.07
Volume 6104675 1 Year -378.05 -50.57
52 Week High 790.30 | 52 Week Low 287.00
 
CO Denmark Most Active Stocks
SAS 0.01 0.00%
NOVO-B 369.55 -0.23%
CONFRZ 0.02 0.00%
VWS 191.65 2.00%
ALMB 17.45 1.28%
VJBA 7.33 0.41%
TRYG 153.10 0.00%
SHAPE 5.03 30.65%
GREENH 0.41 -6.82%
PNDORA 509.00 4.95%
 
CO Denmark Top Gainers Stocks
HYDRCT 0.60 46.34%
SHAPE 5.03 30.65%
HYPE 3.66 22.00%
DKIEEU 249.00 15.81%
SAME 1.45 10.69%
SAME 1.45 10.69%
VIRO 12.70 9.96%
ASTRLS 1.15 8.49%
KLEE-B 4400.00 8.37%
SIG 3.66 7.02%
 
CO Denmark Top Losers Stocks
LEDIBOND 0.02 -33.33%
VALUER 0.25 -21.88%
BLVIS-A 0.40 -18.37%
MDUNDO 3.10 -13.41%
ACT 0.72 -12.20%
ACT 0.72 -12.20%
ACT 0.72 -12.20%
ACT 0.72 -12.20%
ACT 0.72 -12.20%
ACT 0.72 -12.20%
 
 
NOVO-B
Daily Charts
NOVO-B
Intraday Charts
Whats New @
Bazaartrend
NOVO-B
Free Analysis
 
NOVO-B Important Levels Intraday
RESISTANCE391.13
RESISTANCE384.21
RESISTANCE379.93
RESISTANCE375.65
SUPPORT363.45
SUPPORT359.17
SUPPORT354.89
SUPPORT347.97
 
NOVO-B Forecast February 2026
4th UP Forecast893.89
3rd UP Forecast725.73
2nd UP Forecast621.79
1st UP Forecast517.84
1st DOWN Forecast221.26
2nd DOWN Forecast117.31
3rd DOWN Forecast13.37
4th DOWN Forecast-154.79
 
NOVO-B Weekly Forecast
4th UP Forecast472.26
3rd UP Forecast439.32
2nd UP Forecast418.96
1st UP Forecast398.60
1st DOWN Forecast340.50
2nd DOWN Forecast320.14
3rd DOWN Forecast299.78
4th DOWN Forecast266.84
 
NOVO-B Forecast2026
4th UP Forecast1393.17
3rd UP Forecast1064.89
2nd UP Forecast861.97
1st UP Forecast659.05
1st DOWN Forecast80.05
2nd DOWN Forecast-122.87
3rd DOWN Forecast-325.79
4th DOWN Forecast-654.07
 
 
NOVO-B Other Details
Segment EQ
Market Capital 1565371138048.00
Sector Healthcare
Industry Biotechnology
Offical website >
 
NOVO-B Address
NOVO-B
 
NOVO-B Latest News
 
Your Comments and Response on Novo Nordisk A/S
 
NOVO-B Business Profile
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabetic products, obesity, and other chronic diseases. The Biopharmaceuticals segment offers products in the areas of haemophilia, growth disorders, and hormone replacement therapy. The company collaboration agreements with Lund University to develop treatment for Parkinson's diseases; and bluebird bio, Inc. to develop genome editing treatments for children and adult patients. Novo Nordisk A/S also has a research collaboration with Lumen Bioscience, Inc. to explore strategies for delivering oral biologics for cardiometabolic disease. The company was founded in 1923 and is headquartered in Bagsvaerd, Denmark. Address: Novo Allé 1, Bagsvaerd, Denmark, 2880
 
© 2005-2023 BazaarTrend.com All rights reserved.

Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service